$4.54
0.4811.82%
Ult. Agg.: Oct 2, 7:59 PM
$4.52
0.4611.44%
Myriad Genetics (MYGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Myriad Genetics (MYGN) ha pubblicato l'ultima guidance il settembre 16, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $770M - $790M per il periodo.
Rispetto alle previsioni precedenti, Myriad Genetics ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Myriad Genetics ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Myriad Genetics. 29
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.09 | $-0.05 | $-0.05 |
| Actual | $-0.25 | $-0.09 | $0.04 | $0.00 |
| Surprise | -316.7% | 0.00% | +180.0% | +100.0% |
| Revenue | ||||
| Estimate | $205.9M | $202.5M | $207.6M | $205.2M |
| Actual | $190.7M | $200.4M | $209.8M | $205.7M |
| Surprise | -7.38% | -1.02% | +1.07% | +0.26% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.20 | $-0.23 | $-0.24 |
| Revenue | ||||
| Consensus | $190.9M | $195.3M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.25 | $-0.06 | -316.7 % |
| Q1 | May 5, 2026 | $-0.09 | $-0.09 | 0.00 % |
| Q4 | Feb 23, 2026 | $0.04 | $-0.05 | 180.0 % |
| Q3 | Nov 3, 2025 | $0 | $-0.05 | 100.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $190.70M | $205.89M | -7.38 % |
| Q1 | May 5, 2026 | $200.40M | $202.47M | -1.02 % |
| Q4 | Feb 23, 2026 | $209.80M | $207.57M | 1.07 % |
| Q3 | Nov 3, 2025 | $205.70M | $205.17M | 0.26 % |